The possible mechanisms of Picrasma quassiodes (D. Don) Benn. in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in mice

Journal of Ethnopharmacology

Volumn 145, Issue 2, 2013, Pages 424-430

  Zhao, Wenna ^a   Sun, Chen ^a   He, Jiao ^a   Chen, Lin ^a   Zhang, Yongmin ^b   Sun, Wenji ^a  

^a NORTHWEST UNIVERSITY   (China)

^b Université Pierre et Marie Curie   (France)

Author keywords

Cyclooxygenase 2; Cytokines; Inducible nitric oxide synthase; Inflammatory bowel disease; Myeloperoxidase; Picrasma quassiodes (D. Don) Benn.

Indexed keywords

ALCOHOL; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; MYELOPEROXIDASE; PICRASMA QUASSIODES EXTRACT; PLANT EXTRACT; SALAZOSULFAPYRIDINE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COLITIS; COLON INJURY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PICRASMA; PICRASMA QUASSIODES; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; CYCLOOXYGENASE 2; INTERLEUKIN-8; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; PHYTOTHERAPY; PICRASMA; PLANT EXTRACTS; PLANT STEMS; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

MUS; PICRASMA;

EID: 84872148469     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.11.001     Document Type: Article

References (35)

1. S. Ardizzone, and G. Bianchi Porro Biologic therapy for inflammatory bowel disease Drugs 65 2005 2253 2286
2. D.C. Baumgart, and W.J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 2007 1641 1657
3. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzymemarker Journal of Investigative Dermatology 78 1982 206 209
4. L. Camacho-Barquero, I. Villegas, J.M. Sánchez-Calvo, E. Talero, S. Sánchez-Fidalgo, V. Motilva, and C. Alarcón de la Lastra Curcumin, a curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis Immunopharmacology International 7 2007 333 342
5. M. Collino, M. Aragno, R. Mastrocola, M. Gallicchio, A.C. Rosa, C. Dianzani, O. Danni, C. Thiemermann, and R. Fantozzi Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion European of Journal Pharmacology 530 2006 70 80
6. S.J.H. Deventer Tumor necrosis factor and Crohn's disease Gut 40 1997 443 448
7. A.C. Feller, J. Lohler, J. Reimann, and H. Merz Pathogenetic models ulcerative colitis and Crohn disease Verhandlungen der Deutschen Gesellschaftfür Pathologie 80 1996 104 108
8. M.B. Grisham, R.D. Specian, and T.E. Zimmerman Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis Journal of Pharmacology and Experimental Therapeutics 11 1994 14 21
9. J. He, J.R. Liang, S. Zhu, W.N. Zhao, Y.M. Zhang, and W.J. Sun Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice European Journal of Pharmacology 670 2011 229 235
10. M.S. Islam, T. Murata, M. Fujisawa, R. Nagasaka, H. Ushio, A.M. Bari, M. Hori, and H. Ozaki Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice British Journal of Pharmacology 154 2008 812 824
11. W.H. Jiao, H. Gao, F. Zhao, H.W. Lin, Y.M. Pan, G.X. Zhou, and X.S. Yao Anti-inflammatory alkaloids from the stems of Picrasma quassioides BENNET Chemical and Pharmaceutical Bulletin 59 2011 359 364
12. M.R. Khan, M. Kihara, and A.D. Omoloso Antibacterial activity of Picrasma javanica Fitoterapia 72 2001 406 408
13. B.G. Liu, X.M. Jia, Y.Y. Cao, S.H. Chen, H.P. Gao, Y. Wang, Y.Y. Jiang, and Y.B. Cao Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions Journal of Ethnopharmacology 115 2008 1 8
14. J.F. Liu, M. Shao, D.W. Zhai, K. Li, and L.J. Wu Protective effect of 4-methoxy-5-hydroxycanthin-6-one, a natural alkaloid, on dextran sulfate sodium induced rat colitis Planta Medica 75 2009 142 145
15. L. Liu, S.F. Yuan, Y. Sun, Y. Long, Y.H. Li, Y.B. Niu, C. Li, H.Q. Gan, S.S. Cao, and Q.B. Mei The possible mechanisms of fructus mume pill in the treatment of colitis induced by 2, 4, 6-trinitrobenzene sulfonic acid in rats Journal of Ethnopharmacology 126 2009 557 564
16. E. Malle, P.G. Furtmuller, W. Sattler, and C. Obinger Myeloperoxidase: a target for new drug development? British Journal of Pharmacology 152 2007 838 854
17. A.D. Millar, D.S. Rampton, C.L. Chander, A.W.D. Claxson, and D.R. Blake Evaluating the antioxidant potential of new treatments for inflammatory bowel disease in a rat model of colitis Gut 39 1996 407 415
18. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803
19. M.F. Neurath, I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice Journal of Experimental Medicine 182 1995 1281 1290
20. P.M. O'Connor, T.K. Lapointe, P.L. Beck, and A.G. Buret Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease Inflammatory Bowel Diseases 16 2010 1411 1420
21. H. Ogata, and T. Hibi Cytokine and anti-cytokine therapies for inflammatory bowel disease Current Pharmaceutical Design 9 2003 1107 1113
22. E. Pecchi, M. Dallaporta, A. Jean, S. Thirion, and J.D. Troadec Prostaglandins and sickness behavior: old story, new insights Physiology and Behavior 97 2009 279 292
23. Pharmacopoeia of the People's Republic of China Pharmacopoeia of the People's Republic of China [M] vol. 1 2010 China Medical Science and Technology Publishing Co. Beijing p. 186
24. D.K. Podolsky Inflammatory bowel disease New England Journal of Medicine 347 2002 417 429
25. S. Rahman, N. Fukamiya, M. Okano, K. Tagahara, and K.H. Lee Anti-tuberculosis activity of quassinoids Chemical and Pharmaceutical Bulletin 45 1997 1527 1529
26. J.M. Sánchez-Calvo, I. Villegas, S. Sánchez-Fidalgo, L. Camacho-Barquero, E. Talero, V. Motilva, and C. Alarcón de la Lastra Protective effect of curcumin, a curcuma longa constituent, in early colonic inflammation in rats Drug Development Research 70 2009 425 437
27. S. Sánchez-Fidalgo, I. Villegas, A. Martín, M. Sánchez-Hidalgo, and C.A. de la Lastra PARP inhibition reduces acute colonic inflammation in rats European Journal of Pharmacology 563 2007 216 223
28. C.C. Schuerer-Maly, L. Eckmann, M.F. Kagnoff, M.T. Falco, and F.E. Maly Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide Immunology 81 1994 85 91
29. M.S. da Silva, S.S. Fidalgo, E. Talero, A. Cárdeno, M.A. da Silva, W. Villegas, A.R.M.S. Brito, and C.A.D.L. Lastra Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby and Grimes in TNBS colitis model Journal of Ethnopharmacology 128 2010 467 475
30. W. Strober, B.R. Ludviksson, and I.J. Fuss The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease Annals of Internal Medicine 128 1998 848 856
31. E. Talero, S. Sanchez-Fidalgo, C. Alarcon de la Lastra, M. Ilanes, J.R. Calvo, and V. Motilva Acute and chronic responses associated with adrenomedullin administration in experimental colitis Peptides 29 2008 2001 2012
32. D. Thapa, J.S. Lee, S.Y. Park, Y.H. Bae, S.K. Bae, J.B. Kwon, K.J. Kim, M.K. Kwak, Y.J. Park, H.G. Choi, and J.A. Kim Clotrimazole ameliorates intestinal inflammation and abnormal angiogenesis by inhibiting interleukin-8 expression through a nuclear factor-kappa β-dependent manner Journal of Pharmacology and Experimental Therapeutics 327 2008 353 364
33. M. Vulcano, S. Danese, and A. Sica Tolerance in intestinal inflammation and cancer Current Drug Targets 9 2008 404 412
34. Y. Yu, K.L. Seok, and W. Myeong-Hyeon Isolation and biological activities of an alkaloid compound (3-methylcanthin-5, 6-dione) from Picrasma quassiodes (D. Don) Benn Natural Product Sciences 17 2011 5 9
35. N. Yujiro, M. Katsuyoshi, K. Koike, and T. Ohmoto Studies on the gastric antiulcer components from the woods of Picrasma quassioides (Simaroubaceae) Natural Medicines 48 1994 116 121